These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35896321)
21. Platinum-induced hearing loss after treatment for childhood cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906 [TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy. Zhang X; Trendowski MR; Wilkinson E; Shahbazi M; Dinh PC; Shuey MM; ; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Huddart R; Martin NE; Sanchez VA; Frisina RD; Einhorn LH; Cox NJ; Travis LB; Dolan ME Cancer Med; 2022 Jul; 11(14):2801-2816. PubMed ID: 35322580 [TBL] [Abstract][Full Text] [Related]
23. Tinnitus and 3-Year Change in Audiometric Hearing Thresholds. Curhan SG; Halpin C; Wang M; Eavey RD; Curhan GC Ear Hear; 2021; 42(4):886-895. PubMed ID: 33577220 [TBL] [Abstract][Full Text] [Related]
24. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Baguley DM; Prayuenyong P Cancer Chemother Pharmacol; 2020 Feb; 85(2):245-250. PubMed ID: 31865419 [TBL] [Abstract][Full Text] [Related]
25. Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy. Sanchez VA; Shuey MM; Dinh PC; Monahan PO; Fosså SD; Sesso HD; Dolan ME; Einhorn LH; Vaughn DJ; Martin NE; Feldman DR; Kroenke K; Fung C; Frisina RD; Travis LB J Clin Oncol; 2023 Apr; 41(12):2211-2226. PubMed ID: 36626694 [TBL] [Abstract][Full Text] [Related]
26. Association of Hearing Loss and Tinnitus with Health-Related Quality of Life: The Korea National Health and Nutrition Examination Survey. Joo YH; Han KD; Park KH PLoS One; 2015; 10(6):e0131247. PubMed ID: 26121026 [TBL] [Abstract][Full Text] [Related]
27. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Aggarwal P; Nader ME; Gidley PW; Pratihar R; Jivani S; Garden AS; Mott FE; Goepfert RP; Ogboe CW; Charles C; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Hutcheson KA; Shete S Cancer Med; 2023 Jan; 12(1):569-583. PubMed ID: 35695117 [TBL] [Abstract][Full Text] [Related]
28. Hearing impairment after platinum-based chemotherapy in childhood. Einar-Jon E; Trausti O; Asgeir H; Christian M; Thomas W; Måns M; Jon K; Hannes P Pediatr Blood Cancer; 2011 Apr; 56(4):631-7. PubMed ID: 21298751 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of and Characteristics Associated With Self-reported Good Hearing in a Population With Elevated Audiometric Thresholds. Curti SA; Taylor EN; Su D; Spankovich C JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):626-633. PubMed ID: 31169892 [TBL] [Abstract][Full Text] [Related]
30. Trends in Hearing Protection Use With Occupational Noise Exposure in the United States 1999 to 2016. Pan DW; Choi JS; Hokan A; Doherty JK Otol Neurotol; 2022 Jan; 43(1):e14-e22. PubMed ID: 34510117 [TBL] [Abstract][Full Text] [Related]
31. Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors. Miaskowski C; Mastick J; Paul S; Wallhagen M; Abrams G; Levine JD J Cancer Surviv; 2023 Feb; 17(1):59-68. PubMed ID: 36454519 [TBL] [Abstract][Full Text] [Related]
32. Demographic Variations in Tinnitus Subjects with and without Hearing Loss: A Study of 175 Subjects. Sharma A; Munjal S; Panda N; Mohanty M Int Tinnitus J; 2018 Jun; 22(1):77-83. PubMed ID: 29993222 [TBL] [Abstract][Full Text] [Related]
33. Audiometric thresholds and prevalence of tinnitus among male veterans in the United States: data from the National Health and Nutrition Examination Survey, 1999-2006. Folmer RL; McMillan GP; Austin DF; Henry JA J Rehabil Res Dev; 2011; 48(5):503-16. PubMed ID: 21674401 [TBL] [Abstract][Full Text] [Related]
34. Ultra-High Frequency Distortion Product Otoacoustic Emissions for Detection of Hearing Loss and Tinnitus. Jedrzejczak WW; Pilka E; Ganc M; Kochanek K; Skarzynski H Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206311 [TBL] [Abstract][Full Text] [Related]
35. Severity of hearing loss after platinum chemotherapy in childhood cancer survivors. Strebel S; Mader L; Sláma T; Waespe N; Weiss A; Parfitt R; Am Zehnhoff-Dinnesen A; Kompis M; von der Weid NX; Ansari M; Kuehni CE Pediatr Blood Cancer; 2022 Sep; 69(9):e29755. PubMed ID: 35723448 [TBL] [Abstract][Full Text] [Related]
37. Association of Chocolate Consumption with Hearing Loss and Tinnitus in Middle-Aged People Based on the Korean National Health and Nutrition Examination Survey 2012⁻2013. Lee SY; Jung G; Jang MJ; Suh MW; Lee JH; Oh SH; Park MK Nutrients; 2019 Mar; 11(4):. PubMed ID: 30935024 [TBL] [Abstract][Full Text] [Related]
38. Health and Nutrition Examination Survey of 1971-75: Part II. Tinnitus, subjective hearing loss, and well-being. Cooper JC J Am Acad Audiol; 1994 Jan; 5(1):37-43. PubMed ID: 8155893 [TBL] [Abstract][Full Text] [Related]
39. Self-reporting of hearing loss and tinnitus in the diagnosis of ototoxicity by meglumine antimoniate in patients treated for American tegumentary Leishmaniasis. Duarte CCJ; Torraca TSS; Bezerra DO; Oliveira RB; Leite NKS; de Oliveira RVC; Araújo-Melo MH; Pimentel MIF; Costa ADD; Vasconcellos ÉCF; Lyra MR; Soares ECDA; Paes LRDNB; Salgueiro MM; Schubach AO; Valete CM PLoS One; 2024; 19(2):e0296728. PubMed ID: 38354178 [TBL] [Abstract][Full Text] [Related]
40. Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer. Skalleberg J; Solheim O; Fosså SD; Småstuen MC; Osnes T; Gundersen POM; Bunne M Gynecol Oncol; 2017 Apr; 145(1):148-153. PubMed ID: 28202195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]